knowledge -WSS

knowledge

author：leisure time 2025-09-30 22:06:05 - browse：34533

Light at the end of a hospital corridor, where an empty gurney parked — health tech coverage from STAT — Adobe

Health professor Neil Wenger was deep into a years-long study on seriously ill primary care patients when he uncovered a different but persistent issue: Many patients who were targeted for follow-up interventions had actually died, and their hospitals did not know about it.

It wasn’t what Wenger had set out to research. But it was unacceptable, he said, for health systems to lose track of seriously ill primary care patients who’d been treated on-site for years. To be clear, these were not one-time out-of-state patients who’d come in for a single visit.

“When I found a bunch of them were dead and we didn’t actually know it, that’s when I said we need to describe it,” he said. “This is a cohort where we need to know about everyone who is dead.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Ohioans vote in high

entertainment

WSS

Why Novartis is changing the name of its research labs

Why Novartis is changing the name of its research labs

What drug price negotiations mean for Medicare Part D

Medicaid rebukes states for mistakenly disenrolling children

Biden praises World Series champion Astros for impact off the field during White House celebration

Why Novartis is changing the name of its research labs

hotspot

knowledge

leisure time

Medicare proposal to cover medical devices draws a mixed reaction

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

State Dept. review finds Biden bears some blame for Afghanistan failures

Judge rejects Trump's counterclaim against E. Jean Carroll

United colonoscopy coverage change 'may cost lives,' doctors say

Former Georgia lieutenant governor says he received grand jury subpoena

Cancer drug shortages should be causing more outrage

Hospitals use virtual reality to design more inclusive rooms for kids

FDA approval of Sarepta Duchenne genetic therapy gives me hope

More regulation could be coming for drug ads

focus

Sage's campaign to raise awareness of postpartum depression hits a nerve

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

ALS advocates say criticism of new drugs misses bigger picture

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

AstraZeneca chief proposes a novel edit to the drug pricing bill

focus

entertainment

leisure time

explore